Publications
2026
Deep Learning-derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-Type Metastatic Colorectal Cancer
Julius Keyl, René Hosch, Fabian Hörst, Philipp Keyl, Amin Dada, Johannes Haubold, Jannis Straus, Jan Egger, Arndt Stahler, Annika Kurreck, Alexej Ballhausen, Sebastian Stintzing, Stefan Fruehauf, Lothar Müller, Annabel H. S. Alig, Tanja Trarbach, Sylvia Hartmann, Felix Nensa, Jens Kleesiek, Stefan Kasper, Martin Schuler, Dominik P. Modest
Clinical Cancer Research 
